Amyotrophic Lateral Sclerosis
What's New
Last Posted: Jun 06, 2024
- Clinical and genetic factors affecting diagnostic timeline of amyotrophic lateral sclerosis: a 15-year retrospective study.
Ton Fang et al. Neurol Res 2024 1-9 - Explainable machine learning for predicting conversion to neurological disease: Results from 52,939 medical records.
Christina Felix et al. Digit Health 2024 1020552076241249286 - Fluctuating salience in those living with genetic risk of motor neuron disease: A qualitative interview study.
Jade Howard et al. Health Expect 2024 27(2) e14024 - Harnessing Big Data in Amyotrophic Lateral Sclerosis: Machine Learning Applications for Clinical Practice and Pharmaceutical Trials.
Ee Ling Tan et al. J Integr Neurosci 2024 23(3) 58 - Amyotrophic lateral sclerosis: translating genetic discoveries into therapies.
Fulya Akçimen et al. Nat Rev Genet 2023 4 (9) 642-658 - Ensemble-imbalance-based classification for amyotrophic lateral sclerosis prognostic prediction: identifying short-survival patients at diagnosis.
Fabiano Papaiz et al. BMC Med Inform Decis Mak 2024 24(1) 80 - Individuals' experiences in genetic counseling and predictive testing for familial amyotrophic lateral sclerosis.
Connolly G Steigerwald et al. J Genet Couns 2024 - Predicting amyotrophic lateral sclerosis (ALS) progression with machine learning.
Muzammil Arif Din Abdul Jabbar et al. Amyotroph Lateral Scler Frontotemporal Degener 2023 1-14 - The implications of DNA methylation for amyotrophic lateral sclerosis.
Adriana Helena DE Oliveira Reis et al. An Acad Bras Cienc 2023 95(suppl 2) e20230277 - Incorporating Genetic Testing Into the Care of Patients With Amyotrophic Lateral Sclerosis/Frontotemporal Degeneration Spectrum Disorders.
Chelsea Chambers et al. Neurol Clin Pract 2023 13(5) e200201
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: